Beijing, China · Founded 2019 · Privately Held (backing)
Developer of immunotherapy intended to cure solid tumors. GRIT Biotechnology is based in Beijing, China and was founded in 2019. Its last reported valuation was $291 million in Oct 2025. It has raised $124 million.
Last reported valuation
$291.3M
Oct 2026
Priced at
—
Total raised
$124.2M
Last round
—
Cap table — not yet on record
GRIT Biotechnology's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of GRIT Biotechnology with a free account
·The complete investor list: 22 names
·Watch GRIT Biotechnology: the Monday email on marks, rounds and moves
